Compose a new way to ask the same question. The new question must be asking the exact same thing as the original question does. Without any other information, you should be able to tell that the original question and the new question are the same. Preserve bracketed phrases in your new question. You can change the rest of the question provided the above requirements are satisfied. The new question must have a natural, fluent formulation, as if it were composed by a native English speaker. You will be given three pieces of information to help you create better questions. Those are: "Answer": the answer to the question, e.g., "Honolulu". "Answer Type": the type of the answer, e.g., "Location". "Auxiliary Information" is a detailed description of some concepts mentioned in the question, if any.
One example is below.
Q: original question: Who is the museum director of [Science Museum, London]?
answer: Ian Blatchford
answer type: Museum director.
auxiliary information: The Science Museum is a major museum on Exhibition Road in South Kensington, London. It was founded in 1857 and today is one of the city's major tourist attractions, attracting 3.3 million visitors annually. Like other publicly funded national museums in the United Kingdom, the Science Museum does not charge visitors for admission. Temporary exhibitions, however, may incur an admission fee. It is part of the Science Museum Group, having merged with the Museum of Science and Industry in Manchester in 2012.
A: The museum director of the [Science Museum, London] is?
Rationale: The question is correctly paraphrased in this example.
Q: original question: What type of drug is [Adalimumab 50 kit]?
answer: biologic
answer type: Drug formulation category.
auxiliary information: Adalimumab kit, for subcutaneous / topical administration, consisting of: 50mg/mL adalimumab.Indications:HUMIRA is a tumor necrosis factor (TNF) blocker indicated for treatment of: Rheumatoid Arthritis (RA) (1.1) Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active RA. Juvenile Idiopathic Arthritis (JIA) (1.2) Reducing signs and symptoms of moderately to severely active polyarticular JIA in pediatric patients 4 years of age and older. Psoriatic Arthritis (PsA) (1.3) Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active PsA. Ankylosing Spondylitis (AS) (1.4) Reducing signs and symptoms in adult patients with active AS. Crohn's Disease (CD) (1.5) Reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn's disease who have had an inadequate response to conventional therapy. Reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab. Plaque Psoriasis (Ps) (1.6) The treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.
A:
[Adalimumab 50 kit] is which kind of drug?